摘要
目的评价4种用药方案治疗2型糖尿病的经济效果、使用情况及药物疗效。方法运用药物经济学原理及药理学原理对二甲双胍+格列吡嗪(A)、二甲双胍+格列本脲(B)、二甲双胍+格列齐特(C)、二甲双胍+诺和灵30R(D)4种用药方案的成本-药效进行分析。结果总有效率各组间无显著性差异,A、B、C、D组成本-效果比(C/E)分别为0.955、0.182、0.350和2.995,A、C、D组对于B组的增量成本-效果比(△C/△E)分别为17.82、4.39和25.80。结论 4种治疗方案都能将血糖控制在理想范围,但从经济成本及总有效率等方面综合考虑,B方案为较佳选择。
To evaluate the economic effect,medical treatment condition and curative effect of4 kinds of different prescriptions on type 2 Diabetes. Methods to analyze the cost and curative effect of the 4 kinds of prescriptions-Metformin ＋ Glipizide（ A） 、Metformin ＋ Glibenclamide（ B） 、Metformin ＋ Gliclazide（ C） 、Metformin ＋ Novolin 30R,through the principle of medical economics and pharmacology. Results No obvious difference in curative effect,The cost-effect ratio of group A、B、C、D is respectively： 0. 955、0. 182、0. 350 and 2. 995. The overrun cost-effect ratio of group A、C、D to group B is respectively： 17. 82、4. 39 and 25. 80. Conclusion These 4 kinds of prescription can all control the blood sugar to an ideal range . however,considering from cost and total effective rate,etc. comprehensively,scheme B is the better choice.
出处
《中国现代药物应用》
2010年第15期19-20,共2页
Chinese Journal of Modern Drug Application
